×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 0205: THE CONSIDERATIONS OF AMENDMENT FOR DRUG ADMINISTRATION LAW (PART I)
Session Chair(s)
Zhiang Wu, PhD
Shenyang Pharmaceutical University, China
China has initiated the amendment of drug administration law. What will be the key focus of the new law under the new environment? How significant will the changes be? The experts from government, academia, industry and pharmaceutical associations will share perspectives and exchange opinions with audience.
Speaker(s)
Innovation in Management of Drug Safety System
Representative Invited
China
Amendment of Drug Administration Law - The Perspective of Innovation in Drug Regulatory System
Rong SHAO
China Pharmaceutical University(CPU), China
Dean, School of International Pharmaceutical Business
Amendment of Drug Administration Law - The Perspective of Multinational Pharmaceutical Companies
Weiping Li
Xi'An Janssen Pharmaceuticals Ltd., China
Have an account?